CNS Pharmaceuticals ( (CNSP) ) has provided an announcement.

The ocean's biodiversity is a key source of marine-derived compounds, fueling pharmaceutical innovations and drug discovery ...

Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in partnership with the American Association for Cancer Research (AACR), is hosting the 47th ...

Chemotherapy often causes hair loss, but it can depend on the type of chemo drug and other factors. An estimated 65% of people undergoing classic chemotherapy experience hair loss, or what doctors ...

Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in partnership with the American Association for Cancer Research (AACR), hosts the 47th ...

and taxane-based chemotherapy. Kadcyla has been on the market for years, but some setbacks in clinical trials meant it failed to make the swift progress expected in earlier lines of breast cancer ...

in adults with locally advanced or metastatic TNBC without brain metastases – who had received at least two prior chemotherapy regimens including a taxane – compared with a range of single ...

Barnett et al. explore the role of blood-based tumor mutation burden in predicting outcomes to immune checkpoint inhibitors in patients with advanced breast or prostate cancers. They find immune ...

Aims: To determine the maximum tolerated dose (MTD), safety and anti-tumor activity of afatinib combined with docetaxel in advanced cancer. Patients & methods: The MTD was determined from dose ...